Radioimmunotherapy for Non-Hodgkin Lymphoma : Historical Perspective and Current Status
Author:
Affiliation:
1. Department of Medical Oncology, Interbalkan Hospital, Thessaloniki, Greece
Publisher
Japanese Society for Lymphoreticular Tissue Research
Subject
General Medicine
Link
https://www.jstage.jst.go.jp/article/jslrt/47/2/47_2_43/_pdf
Reference89 articles.
1. 1 Wilder RB, DeNardo GL, DeNardo SJ : Radioimmunotherapy : recent results and future directions. J Clin Oncol 14 : 1383-1400, 1996
2. 2 DeNardo GL, O'Donnell RT, Rose LM, Mirick GR, Kroger LA, DeNardo SJ : Milestones in the development of Lym-1 therapy. Hybridoma 18 : 1-11, 1999
3. 3 Koizumi K, DeNardo GL, DeNardo SJ, Hays MT, Hines HH, Scheibe PO, Peng JS, Macey DJ, Tonami N, Hisada K : Multicompartmental analysis of the kinetics of radioiodinated monoclonal antibody in patients with cancer. J Nucl Med 27 : 1243-1254, 1986
4. 4 DeNardo SJ, DeNardo GL, O'Grady LF, Macey DJ, Mills SL, Epstein AL, Peng JS, McGahan JP : Treatment of a patient with B cell lymphoma by I-131 LYM-1 monoclonal antibodies. Int J Biol Markers 2 : 49-53, 1987
5. 5 DeNardo SJ, DeNardo GL, O'Grady LF, Hu E, Sytsma VM, Mills SL, Levy NB, Macey DJ, Miller CH, Epstein AL : Treatment of B cell malignancies with 131I Lym-1 monoclonal antibodies. Int J Cancer (Suppl) 3 : 96-101, 1988
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Radionuclide Therapy in Lymphoproliferative Diseases;Radionuclide Therapy;2022
2. Safety of 90Y-ibritumomab Tiuxetan Treatment for Japanese Patients in Real-world Clinical Practice;YAKUGAKU ZASSHI;2019-01-01
3. Biodistribution and Dosimetry of Indigenously Produced 131I-Rituximab in B-Cell Lymphoma: Pilot Study Estimating Patient-Specific Dose Comparing 2 Different Dosimetric Methods;Journal of Nuclear Medicine Technology;2018-11-09
4. Pharmacokinetics of radiolabeled dimeric sdAbs constructs targeting human CD20;New Biotechnology;2018-10
5. Radioimmunotherapy in Oncology;Current Radiology Reports;2017-10-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3